About MS          Programs          News Center          Publications          Videos          Site Preferences          Contact MSAA          Home
Login          Register Now          Why Register?          Print Page

The Multiple Sclerosis Coalition

The Multiple Sclerosis Coalition (MSC) is an affiliation of independent MS organizations dedicated to the enhancement of the quality of life for all those affected by MS.

Founding Members:
Consortium of Multiple Sclerosis Centers (www.mscare.org)
Multiple Sclerosis Association of America (www.msassociation.org)
Multiple Sclerosis Foundation (www.msfocus.org )

Other Members:
Accelerated Cure Project for Multiple Sclerosis
International Organization of Multiple Sclerosis Nurses (www.iomsn.org)
National Multiple Sclerosis Society (www.nmss.org )
Can Do Multiple Sclerosis www.mscando.org
United Spinal Association (www.unitedspinal.org)

Mission of the Multiple Sclerosis Coalition

The MSC's mission is to increase opportunities for cooperation and provide greater opportunity to leverage the effective use of resources for the benefit of the MS community.

About the Coalition

The primary objectives of the MSC are to educate, advocate, collaborate, and improve the efficiency of services for individuals with MS and those who are close to them. With so much on the horizon in terms of MS research, treatments, advocacy, and symptom management, the MSC provides critical momentum to work together to ensure this collective support continues. For more information on the MSC please visit: www.ms-coalition.org.

Coalition Committees

Executive Committee
President: Doug Franklin, Multiple Sclerosis Association of America
Vice-President: Jules Kuperberg, Multiple Sclerosis Foundation
Secretary: Heidi Heltzel, Can Do Multiple Sclerosis
Treasurer: Ted Thompson, National Multiple Sclerosis Society

Coalition Resources

Multiple Sclerosis Coalition Brochure

Multiple Sclerosis Emerging Therapies Collaborative

The Multiple Sclerosis Emerging Therapies Collaborative has been organized to provide timely, evidence-based resources regarding the known benefits and risks of newly emerging, FDA-approved medications for multiple sclerosis (MS).



Last Updated: Thursday, March 21, 2013